申请人:Hoffmann-La Roche Inc.
公开号:US06331642B1
公开(公告)日:2001-12-18
Compounds of the formula
wherein
R1 is hydrogen or an alkyl group;
R2 is hydrogen or an alkyl group; or
R1, R2 and C20 together are cyclopropyl;
R3 is alkyl, hydroxy-alkyl or fluoroalkyl; and
R4 is alkyl, hydroxy-alkyl or fluoroalkyl which are useful in the treatment of breast cancer, prostate cancer, myeloid leukemia benign prostate growth, baldness and osteoporosis.
该式化合物中,其中R1是氢或烷基;R2是氢或烷基;或R1,R2和C20一起是环丙基;R3是烷基,羟基烷基或氟烷基;R4是烷基,羟基烷基或氟烷基,可用于治疗乳腺癌、前列腺癌、骨髓性白血病、良性前列腺增生、脱发和骨质疏松症。